Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MIDAZOLAM HYDROCHLORIDE

MIDAZOLAM HYDROCHLORIDE

Standard Dose
EQ 2MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MIDAZOLAM HYDROCHLORIDE is listed in Drugs@FDA under application 077115 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SYRUP;ORAL - EQ 2MG BASE/ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2023-01-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview MIDAZOLAM HYDROCHLORIDE is listed in Drugs@FDA under application 077115 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SYRUP;ORAL - EQ 2MG BASE/ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2023-01-17 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.